Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Ford

Showing results (131-140 of 458) with videos related to

Pageof 46
Sort By:
Plos One|July 30, 2013
Outcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysisPrinitha Pillay, Nathan Ford, Zara Shubber, et al.
Disasters|June 27, 2003
Mortality, violence and lack of access to healthcare in the Democratic Republic of CongoMichel Van Herp, Veronique Parqué, Edward Rackley, et al.
HIV/AIDS (Auckland, N.Z.)|November 19, 2011
Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settingsNathan Ford, Janice Lee, Isabelle Andrieux-Meyer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2020
The Enduring Burden of Advanced Human Immunodeficiency Virus DiseaseNathan Ford, Eric Goemaere, Katherine Hildebrand, et al.
Open Forum Infectious Diseases|September 7, 2017
Risk of Tuberculosis Infection and Disease for Health Care Workers: An Updated Meta-AnalysisLydia Uden, Ella Barber, Nathan Ford, et al.
The Lancet. Global Health|July 28, 2018
Assessing the risk of dolutegravir for women of childbearing potentialMichael Schomaker, Mary-Ann Davies, Morna Cornell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2014
Editorial commentary: Comparative efficacy of lamivudine and emtricitabine: comparing the results of randomized trials and cohortsNathan Ford, Andrew Hill, Marco Vitoria, et al.
AIDS (London, England)|January 6, 2016
Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIVSaskia Den Boon, Alberto Matteelli, Nathan Ford, et al.
BMJ (Clinical Research Ed.)|December 11, 2020
The time to act is now: pseudo-systematic reviewNathan Ford, Grania Brigden, Tom Ellman, et al.
Current Opinion in HIV and AIDS|June 5, 2020
Global public health efforts to address HIV and related communicable disease syndemicsNathan Ford, Teodora Wi, Philippa Easterbrook, et al.
Pageof 46

Showing results (131-140 of 458) with videos related to

Sort By:
Pageof 46
Plos One|July 30, 2013
Outcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysisPrinitha Pillay, Nathan Ford, Zara Shubber, et al.
Disasters|June 27, 2003
Mortality, violence and lack of access to healthcare in the Democratic Republic of CongoMichel Van Herp, Veronique Parqué, Edward Rackley, et al.
HIV/AIDS (Auckland, N.Z.)|November 19, 2011
Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settingsNathan Ford, Janice Lee, Isabelle Andrieux-Meyer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2020
The Enduring Burden of Advanced Human Immunodeficiency Virus DiseaseNathan Ford, Eric Goemaere, Katherine Hildebrand, et al.
Open Forum Infectious Diseases|September 7, 2017
Risk of Tuberculosis Infection and Disease for Health Care Workers: An Updated Meta-AnalysisLydia Uden, Ella Barber, Nathan Ford, et al.
The Lancet. Global Health|July 28, 2018
Assessing the risk of dolutegravir for women of childbearing potentialMichael Schomaker, Mary-Ann Davies, Morna Cornell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2014
Editorial commentary: Comparative efficacy of lamivudine and emtricitabine: comparing the results of randomized trials and cohortsNathan Ford, Andrew Hill, Marco Vitoria, et al.
AIDS (London, England)|January 6, 2016
Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIVSaskia Den Boon, Alberto Matteelli, Nathan Ford, et al.
BMJ (Clinical Research Ed.)|December 11, 2020
The time to act is now: pseudo-systematic reviewNathan Ford, Grania Brigden, Tom Ellman, et al.
Current Opinion in HIV and AIDS|June 5, 2020
Global public health efforts to address HIV and related communicable disease syndemicsNathan Ford, Teodora Wi, Philippa Easterbrook, et al.
Pageof 46